Scientists probe immune signals in spine disease
NCT ID NCT07396194
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will measure levels of certain immune proteins (IL-17, IL-38, IL-41) and the HLA-B27 gene in 84 people with ankylosing spondylitis and a healthy control group. The goal is to see if these markers are linked to disease activity and severity. No treatment is given; the study only collects blood samples for analysis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANKYLOSING SPONDYLITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a gut microbiome transplant ease axial spondyloarthritis?
- Could a simple protein test unlock the secrets of joint disease?
- Can a biologic drug safely tame Back-Joint inflammation? a Real-World trial investigates
- New antibody aims to calm ankylosing spondylitis
- Can a 4-Minute chat rival a Dietitian's hour for heart health?
- Ultrasound and EMG may tell inflammatory from mechanical shoulder issues